
|

| |
Track the *RXDLV Index |
 |
|
 | Drug Delivery Stocks (*RXDLV) |
| |
Drug Delivery Ideas |
|
|
|
Drug Delivery Performance |
|
|
|
Drug Delivery Community |
|
| |
|
Index Description: Companies that focus on technology for delivering pharmaceuticals - pills, patches, sprayes and more are represented here
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.3%
+0.1%
+37.1%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+1.0%
-5.1%
+17.0%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$3.1B
12.4
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ACRX |
$7.26 |
+0.86 |
+13.4% |
996,826 |
275% |
$270.3M |
- |
220% |
-2% |
No Alerts/News
|
|
|
| ALKS |
$31.75 |
-0.23 |
-0.7% |
1,550,166 |
92% |
$4.2B |
- |
114% |
-4% |
No Alerts/News
|
|
|
| APRI |
$3.30 |
-0.11 |
-3.2% |
657,170 |
221% |
$100.1M |
- |
75% |
-9% |
2 Alerts (2 News) - View
|
|
|
| BDSI |
$4.20 |
-0.14 |
-3.2% |
332,828 |
135% |
$159.5M |
- |
35% |
-39% |
1 Alert (0 News) - View
|
|
|
| CBRX |
$0.62 |
0.00 |
0.0% |
175,546 |
57% |
$54.2M |
- |
13% |
-50% |
No Alerts/News
|
|
|
| DRRX |
$0.91 |
-0.04 |
-4.4% |
550,100 |
62% |
$92.5M |
- |
49% |
-51% |
1 Alert (0 News) - View
|
|
|
| FLML |
$4.63 |
-0.02 |
-0.4% |
27,929 |
53% |
$115.5M |
- |
62% |
-18% |
No Alerts/News
|
|
|
| HSP |
$35.40 |
-0.52 |
-1.4% |
933,066 |
68% |
$5.8B |
- |
24% |
-6% |
No Alerts/News
|
|
|
| KVPHQ |
$0.12 |
+0.01 |
+9.1% |
36,333 |
32% |
$7.1M |
- |
362% |
-92% |
No Alerts/News
|
|
|
| NKTR |
$9.24 |
-0.49 |
-5.0% |
1,888,638 |
199% |
$1.0B |
- |
64% |
-19% |
1 Alert (0 News) - View
|
|
|
| VRX |
$74.82 |
-0.71 |
-0.9% |
871,930 |
70% |
$22.7B |
- |
76% |
-5% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Pharma M&A – Actavis to Acquire Warner Chilcott FRX MYL TEVA ACT VRX WCRX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com) On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner
Flag
Post a comment
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal MYL VRX WCRX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com) Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion
Flag
Post a comment
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 ALKS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 04:00PM from (www.businesswire.com) Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss
Flag
Post a comment
Alkermes Elects Nancy Wysenski to Board of Directors ALKS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:00AM from (www.businesswire.com) Alkermes plc (NASDAQ: ALKS) today announced the election of Nancy J. Wysenski to the company’s Board of Directors. Most
Flag
Post a comment
What We're Reading ~ Analytical Links 5/15/13 VZ VOD DLTR HSP FLT
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com) Meb Faber's new book: Shareholder Yield [Meb Faber]
Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
Flag
Post a comment
Michael Price's Presentation at London Value Conference: Long Hospira & Hess HES HSP BRK.A
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 13, 01:52PM from (www.marketfolly.com) Continuing our notes from the London Value Investor Conference 2013, the next speaker is Michael Price of MFP Investors.
Flag
Post a comment
Apricus Biosciences Provides First Quarter 2013 Corporate Update APRI
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:43AM from (globenewswire.com) SAN DIEGO, May 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")
Flag
Post a comment
DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update APRI
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:43AM from (globenewswire.com)
Apricus Biosciences, Inc.
10.05.2013 14:30
---------------------------------------------------------------------------
Flag
Post a comment
Hospira Sues B. Braun Over Infusion-Pump System Patents HSP
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 09, 11:09AM from (www.bloomberg.com) Hospira Inc. (HSP), a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.
Flag
Post a comment
|
|
|